Trials / Unknown
UnknownNCT05151055
Lactoferrin + Vitamin E + Zinc for Hormonal Acne
A Randomized, Double-Blind, Placebo-Controlled Trial To Determine The Safety and Efficacy of Lactoferrin With Vitamin E and Zinc as an Oral Therapy for Mild to Moderate Hormonal Acne in Adult Women
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- Sponsor
- United Laboratories · Industry
- Sex
- Female
- Age
- 22 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
We previously showed that twice daily intake of a combination of 100 mg lactoferrin, 11 IU vitamin E, and 5 mg zinc significantly reduced both inflammatory and non-inflammatory acne lesions compared to placebo control. In that study, females showed an overall better response compared to males in terms of total lesions. We speculated that the gender effect may be due to mitigation of the pre- menstrual flare-ups women have that lead to recurring acne, making them have a better response. The objectives of this study are: 1.) to characterize the efficacy and safety of 100 mg lactoferrin + 11 IU vitamin E + 5 mg zinc in the adult female population who suffer from hormonal acne, 2.) to determine whether the anti-acne effect is maintained after treatment stops.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactezin | 100 mg lactoferrin, 11 IU vitamin E (as alpha tocopherol), and 5 mg zinc (as zinc gluconate) |
| DIETARY_SUPPLEMENT | Placebo | starch |
Timeline
- Start date
- 2020-03-02
- Primary completion
- 2022-06-01
- Completion
- 2022-09-01
- First posted
- 2021-12-09
- Last updated
- 2021-12-09
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT05151055. Inclusion in this directory is not an endorsement.